Alamar signals $121M-$123M 2026 revenue while planning ARGO HT/DX FDA submission by end of next year

• CEO Yuling Luo said Q3 revenue momentum and margin expansion led the company to raise its full-year outlook, stating, “Total revenue for the third quarter grew 68% year-over-year, led by consumables, which grew 79% and made

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.